hnRNP K expression and its clinical significance in human lung cancer tissues

Chinese Journal of Lung Cancer

Volumn 11, Issue 2, 2008, Pages 241-245

  Chen, Yan ^a   Li, Weimin ^b   Zhang, Shangfu ^c  

^a Central Hospital of Nanchong   (China)

^b SICHUAN UNIVERSITY   (China)

^c NONE

Author keywords

Heterogeneous nuclear ribonucleoprotein K; Immunohistochemistry; Lung neoplasms

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN KINASE; NUCLEAR PROTEIN;

ARTICLE; CANCER DIAGNOSIS; CANCER THERAPY; CANCER TISSUE; CELL NUCLEUS; CONTROL GROUP; CONTROLLED STUDY; CYTOPLASM; DISEASE CLASSIFICATION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; SAMPLING; STAINING; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION;

EID: 43649100591     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2008.02.017     Document Type: Article

References (10)

1. Guan J ed. The abstract of the fifth Europe lung cancer conference. Continuing Medical Education, 2005, 19(02): 56-57.
2. Bomsztyk K, Denisenko O, Ostrowski J. One protein multiple processes. Bioessays, 2004, 26(6): 629-38.
3. Klimek-Tomczak K, Mikula M, Dzwonek A, et al. Editing of hnRNP K proteinmRNA in colorectal adenocarcinoma and surrounding mucosa. Br J Cancer, 2006, 94 (4): 586-92.
4. Mandal M, Vadlamudi R, Nguyen D, et al. Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression function. Biochem J , 2001, 27(6): 9699-9704.
5. Brendel C, Rehbein M, Kreienkamp HJ, et al. Characterization of Staufen 1 ribonucleoprotein complexes.Biochem J, 2004, 384 (2): 239-246.
6. Laury-Kleintop LD, Tresini M, Ostrowski J. Compartmentalization of hnRNP-K during cell cycle progression and its interaction with calponin in the cytoplasm. Cell Biochem, 2005, 95(5): 1042-1056.
7. Evans JR, Mitchell SA, Spriggs KA, et al. Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene, 2003, 22 (39): 6068-6076.
8. Notari M, Neviani P, Santhanam R, et al. A MAPK/HNRNPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood, 2006, 107 (6): 2507-2516.
9. Pino I, Pio R, Toledo G, et al. Altered patterns of expression of members of theheterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer, 2003, 41 (2): 131-143.
10. Huang J, Chen XH, Xu P. The function of heterogeneous nuclear ribonucleoprotein in pre-mRNA processing. Chin J Cell Biol, 2004, 26(4): 277-380.